DETERMINE Trial Treatment Arm 06: Capmatinib in Adult Patients With Cancers Harbouring MET Dysregulations — StellaPhase 2 — Testing in a larger group (up to a few hundred people) to further evaluate safety and begin to assess effectiveness.
Trial locations(17 sites)
United Kingdom
Belfast City Hospital, Belfast University Hospital Birmingham, Birmingham Bristol Haematology and Oncology Centre, Bristol Addenbrooke's Hospital, Cambridge Velindre Cancer Centre, Cardiff Western General Hospital, Edinburgh The Beatson Hospital, Glasgow Leicester Royal Infirmary, Leicester University College London Hospital, London The Christie Hospital, Manchester Clatterbridge Cancer Centre, Metropolitan Borough of Wirral Freeman Hospital, Newcastle Churchill Hospital, Oxford Western Park Hospital, Sheffield Southampton General Hospital, Southampton Royal Marsden Hospital, Sutton Age range
18 Years and older
Last updated November 2025